scout
|Videos|April 27, 2017

How Oral Targeted Therapies and IV Immunotherapies Disrupted Community Practice Financing

Barbara McAneny, MD, the chief executive officer of New Mexico Cancer Center, discusses how oral targeted therapies and immunotherapies disrupted the traditional methods for financing community practices.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME